LATERAL FLOW ANTIGEN TEST PROFESSIONAL

Upload your test result to our secure online portal to receive your travel certificate

COVID-19 ANTIGEN LATERAL FLOW TEST WITH FIT TO FLY TRAVEL CERTIFICATE – Easy to use at home lateral flow test with rapid results within 30 minutes.

The certificate is Approved by all airlines, cruise liners and border agencies around the world This test can be used as a Fit To Fly or Pre-Departure test for any country requiring a verified test fit to fly testĬertificate will be provided 2 working hours (working hours are 8am to 7pm Monday to Saturday) Upload your photographic evidence of your negative test result via our online secure portal for your travel certificate certificated by our UKAS accredited laboratory. (8am to 7pm Monday to Saturday)Ī self-administered lateral flow test providing a positive or negative result for COVID-19 in 30 minutes. Test Certificate provided within 2 working hours of receiving lateral flow test result. Potentially, LFDs could support the scaling up of mass testing to aid track and trace methodology and break the chain of transmission of COVID-19 with the additional benefit of providing individuals with the results in a much shorter time frame.ĬOVID-19 Coronavirus Lateral flow device Lateral flow test Mass testing Population testing Rapid antigen detection Reverse transcriptase polymerase chain reaction SARS-CoV-2 Viral antigen detection.This is the test you need if you require a fit to fly travel certificate to show your negative COVID result from a lateral flow test for travel. Test performance does not appear dependent on the operator. Some perform with high specificity but a great range of sensitivities were shown (38.32-99.19%). This systematic review identified that the performance of lateral flow devices is heterogeneous and dependent on the manufacturer.

LATERAL FLOW ANTIGEN TEST PROFESSIONAL

Operation of the test by a trained professional or by the test subject with self-swabbing produced comparable results. Twenty-four papers were identified involving over 26,000 test results. Data was pooled based on manufacturer of LFD and split based on operator (self-swab or by trained professional) and sensitivity and specificity data were calculated.

Based on extracted data sensitivity and specificity was calculated for each study. Our aims were to assess the sensitivity and specificity of LFDs in a systematic review and summarise the sensitivity and specificity of these tests.Ī targeted search of Pubmed and Medxriv, using PRISMA principles, was conducted identifying clinical studies assessing the sensitivity and specificity of LFDs as their primary outcome compared to reverse transcriptase polymerase chain reaction (RT-PCR) for the detection of SARS-CoV-2. There are now several studies assessing their accuracy but as yet no systematic review. They have been advocated for use by the World Health Organisation to help control outbreaks and break the chain of transmission of COVID-19 infections. Lateral flow devices (LFDs) are viral antigen tests for the detection of SARS-CoV-2 that produce a rapid result, are inexpensive and easy to operate.

Lateral flow antigen test